Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

Carcinogenicity of deoxycholate, a secondary bile acid

(2011) Carol Bernstein et al.   ARCHIVES OF TOXICOLOGY

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

(2011) Helena Tlaskalová-Hogenová et al.   Cellular & Molecular Immunology

Farnesoid X receptor agonists for primary biliary cirrhosis

(2011) Keith D Lindor   CURRENT OPINION IN GASTROENTEROLOGY

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

(2011) R. M. Gadaleta et al.   GUT

Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis

(2011) Natalie A. Molodecky et al.   HEPATOLOGY

Genome-wide association studies in primary sclerosing cholangitis: Still more questions than answers?

(2011) Roger Chapman   HEPATOLOGY

Risk of Colonic Neoplasia After Liver Transplantation for Primary Sclerosing Cholangitis

(2011) Ibrahim A. Hanouneh et al.   INFLAMMATORY BOWEL DISEASES

The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch–anal anastomosis for ulcerative colitis

(2011) Monira Rahman et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease

(2010) Raffaella M. Gadaleta et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

(2010) Erin W. Thackeray et al.   Clinical Gastroenterology and Hepatology

Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer

(2010) Marco Candela et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Bile salts and cholestasis

(2010) Lucas Maillette de Buy Wenniger et al.   DIGESTIVE AND LIVER DISEASE

Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal Homeostasis

(2010) R. Balfour Sartor   GASTROENTEROLOGY

AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

(2010) Francis A. Farraye et al.   GASTROENTEROLOGY

In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival

(2010) Gerda Rudolph et al.   JOURNAL OF HEPATOLOGY

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

(2010) Espen Melum et al.   NATURE GENETICS

Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

(2009) Tom H. Karlsen et al.   GASTROENTEROLOGY

Diagnosis and management of primary sclerosing cholangitis

(2009) Roger Chapman et al.   HEPATOLOGY

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides fragilis, in Wild-Type C57BL/6 Mice

(2009) K.-J. Rhee et al.   INFECTION AND IMMUNITY

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis

(2009) M. M.H. Claessen et al.   INFLAMMATORY BOWEL DISEASES

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

(2009)   JOURNAL OF HEPATOLOGY

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

(2009) P. Vavassori et al.   JOURNAL OF IMMUNOLOGY

Bile acids: regulation of synthesis

(2009) John Y. L. Chiang   JOURNAL OF LIPID RESEARCH

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

(2009) Shaoguang Wu et al.   NATURE MEDICINE

Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

(2009) Joshua M. Uronis et al.   PLoS One

Tumor Necrosis Factor-Alpha Polymorphisms in Ulcerative Colitis-Associated Colorectal Cancer

(2008) Megan M. Garrity-Park et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis

(2008) S. Modica et al.   CANCER RESEARCH

Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?

(2008) Ulrich Beuers et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

Adenocarcinoma following ileal pouch–anal anastomosis for ulcerative colitis: Review of 26 cases

(2008) Bernardino C. Branco et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the management of ulcerative colitis: Special situations

(2008) Livia Biancone et al.   Journal of Crohns & Colitis

High lifetime risk of cancer in primary sclerosing cholangitis

(2008) Marian M.H. Claessen et al.   JOURNAL OF HEPATOLOGY

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

(2008) Stephan Brackmann et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Intestinal bile acid physiology and pathophysiology

(2008) Olga Martínez-Augustin et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis

(2008) Harry Sokol et al.   WORLD JOURNAL OF GASTROENTEROLOGY